Xiamen, China

Haifeng Pan

This inventor holds 1 USPTO granted patent. Top assignees: Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., Xiamen University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haifeng Pan. Retrieved from https://idiyas.com/inventor/haifeng-pan-bs7vkxtn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Haifeng Pan: Innovator in Coronavirus Detection

Introduction

Haifeng Pan is a notable inventor based in Xiamen, China. He has made significant contributions to the field of biological detection, particularly in relation to the 2019 novel coronavirus. His work has implications for public health and safety.

Latest Patents

Haifeng Pan holds a patent for an "Antigen for 2019 Novel Coronavirus and Detection Use Thereof." This patent represents a crucial advancement in the detection of the virus, which has impacted millions globally. His innovative approach aids in the rapid identification of the virus, facilitating timely responses to outbreaks.

Career Highlights

Throughout his career, Haifeng Pan has worked with reputable organizations, including Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. and Xiamen University. His experience in these institutions has allowed him to develop and refine his expertise in biological research and innovation.

Collaborations

One of his notable collaborators is Qiaoyun Shi, who has contributed to his research efforts. Their partnership exemplifies the importance of teamwork in advancing scientific discoveries.

Conclusion

Haifeng Pan's contributions to the field of coronavirus detection highlight his role as an important inventor in modern science. His work not only showcases his innovative spirit but also emphasizes the critical need for advancements in public health technologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…